The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

prn  -  pertactin autotransporter

Bordetella pertussis Tohama I

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of prn

  • The cloned P.69 (prn) gene of B. pertussis was insertionally inactivated with a kanamycin-resistance cassette [1].
  • The gene prn encoding the outer-membrane protein P.70 (pertactin) from Bordetella parapertussis has been cloned in Escherichia coli and its DNA sequence determined [2].
  • The P.69 Bordetella pertussis protective antigen was expressed by use of the trc promoter from the chromosome of a Salmonella typhimurium aro vaccine strain, BRD509, by integrating the prn gene, encoding the 93-kDa precursor of this protein, into the aroC locus [3].
  • Salmonella strains expressing surface-associated P.69/pertactin from a chromosomally located prn gene were significantly more invasive than isogenic parental strains [4].
 

High impact information on prn

  • We have therefore used the RIVET system to reveal the time-course of gene expression in vivo for selected B. pertussis virulence factors (cya, fha, prn and ptx) [5].
  • A strain containing a mutation in fhaB was significantly less adhesive and invasive than its parent, and a prn fhaB double mutant exhibited an even greater reduction in adhesiveness and invasiveness down to levels comparable with a Vir- strain [1].
  • The analyses included serotyping of fimbriae (Fim), genotyping of the pertussis toxin S1 subunit (ptxA) and pertactin (prn), and pulsed-field gel electrophoresis (PFGE) after digestion of B. pertussis genomic DNA with XbaI restriction enzyme [6].
  • In modern isolates, polymorphism was observed only in prn, ptxS1, ptxS3, and tcfA [7].
  • We used a number of methods, including prn-lac fusions, reverse transcriptase PCR, and 5' rapid amplification of cDNA ends, to localize and identify the bvg-dependent 5' end of the prn transcript to the cytosine at -125 with respect to the published start site [8].
 

Biological context of prn

  • It has been shown by transcription activation kinetics that several of the virulence factors are differentially regulated. fha is transcribed within 10 min following a bvgAS-inducing signal, while prn is transcribed after 1 h and ptx is not transcribed until 2 to 4 h after induction [9].
  • We have identified cis-acting sequences necessary for expression of prn in B. pertussis by using prn-lac fusions containing alterations in the sequence upstream of the prn open reading frame [8].
  • However, these data do not support the location of the prn transcription start site as previously published [8].
  • Escherichia coli K-12 strain HB101 harbouring the plasmid p41869D, which encodes the full-length prn gene under the control of the tac promoter on the broad-host-range plasmid pMMB66EH, was significantly more adhesive to HEp-2 and Chinese Hamster Ovary (CHO) cells growing in culture than E. coli HB101(pMMB66EH) [4].
  • Interestingly, one gene belonging to the bvg virulence regulon behaved differently: the promoter of the prn locus, coding for the outer membrane protein pertactin, involved in bacterial adhesion to eukaryotic cells, was induced after inhibition of DNA gyrase [10].
 

Other interactions of prn

 

Analytical, diagnostic and therapeutic context of prn

References

  1. Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Roberts, M., Fairweather, N.F., Leininger, E., Pickard, D., Hewlett, E.L., Robinson, A., Hayward, C., Dougan, G., Charles, I.G. Mol. Microbiol. (1991) [Pubmed]
  2. P.70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli. Li, L.J., Dougan, G., Novotny, P., Charles, I.G. Mol. Microbiol. (1991) [Pubmed]
  3. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Strugnell, R., Dougan, G., Chatfield, S., Charles, I., Fairweather, N., Tite, J., Li, J.L., Beesley, J., Roberts, M. Infect. Immun. (1992) [Pubmed]
  4. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Everest, P., Li, J., Douce, G., Charles, I., De Azavedo, J., Chatfield, S., Dougan, G., Roberts, M. Microbiology (Reading, Engl.) (1996) [Pubmed]
  5. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET. Veal-Carr, W.L., Stibitz, S. Mol. Microbiol. (2005) [Pubmed]
  6. Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. Elomaa, A., Advani, A., Donnelly, D., Antila, M., Mertsola, J., Hallander, H., He, Q. J. Clin. Microbiol. (2005) [Pubmed]
  7. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. van Loo, I.H., Heuvelman, K.J., King, A.J., Mooi, F.R. J. Clin. Microbiol. (2002) [Pubmed]
  8. Analysis of BvgA activation of the pertactin gene promoter in Bordetella pertussis. Kinnear, S.M., Boucher, P.E., Stibitz, S., Carbonetti, N.H. J. Bacteriol. (1999) [Pubmed]
  9. Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity. Kinnear, S.M., Marques, R.R., Carbonetti, N.H. Infect. Immun. (2001) [Pubmed]
  10. Global regulatory mechanisms affect virulence gene expression in Bordetella pertussis. Graeff-Wohlleben, H., Deppisch, H., Gross, R. Mol. Gen. Genet. (1995) [Pubmed]
  11. Temporal trends in circulating Bordetella pertussis strains in Australia. Poynten, M., McIntyre, P.B., Mooi, F.R., Heuvelman, K.J., Gilbert, G.L. Epidemiol. Infect. (2004) [Pubmed]
  12. Antigenic divergence of Bordetella pertussis isolates in Taiwan. Yao, S.M., Lin, Y.C., Chou, C.Y., Chen, Y.Y., Hsiao, M.J., Chen, H.Y., Yan, J.J., Su, H.P., Li, S.Y. J. Clin. Microbiol. (2005) [Pubmed]
  13. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. Kourova, N., Caro, V., Weber, C., Thiberge, S., Chuprinina, R., Tseneva, G., Guiso, N. J. Clin. Microbiol. (2003) [Pubmed]
  14. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Guiso, N., Boursaux-Eude, C., Weber, C., Hausman, S.Z., Sato, H., Iwaki, M., Kamachi, K., Konda, T., Burns, D.L. Vaccine (2001) [Pubmed]
  15. Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain. Charles, I., Fairweather, N., Pickard, D., Beesley, J., Anderson, R., Dougan, G., Roberts, M. Microbiology (Reading, Engl.) (1994) [Pubmed]
  16. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Fingermann, M., Fernández, J., Sisti, F., Rodríguez, M.E., Gatti, B., Bottero, D., Graieb, A., Gaillard, M.E., Ayala, S.G., Mooi, F.R., Lopardo, H., Hozbor, D. Vaccine (2006) [Pubmed]
 
WikiGenes - Universities